Acylcarnitines in intermediary metabolism

European Journal of Pediatrics
A Sewell, H Böhles

Abstract

From the time of its discovery in 1905 until the first description of its deficiency in 1973, the role of carnitine in intermediary metabolism was decidedly vague. Identification of carnitine acyl transferases and their products, acylcarnitines, have paved the way to the confirmation of the importance of carnitine in the transfer of fatty acid CoAs into the mitochondrion for beta-oxidation and energy production. The elucidation of defects in fatty acid oxidation together with the concept of carnitine therapy in certain organoacidaemias have given a new meaning to the term acylcarnitine. Not only are these compounds of diagnostic importance, their formation may be part of a secondary carnitine depletion which may be brought about as a result of various medications. Recent evidence suggests that long-chain acylcarnitines are responsible for cardiac arrhythmias and other effects, both good and bad, will certainly be found. This review will attempt to highlight the importance of acylcarnitines, from their production, the difficulties in analysis, the diagnostic possibilities and their positive and negative effects on intermediary metabolism.

References

Jul 1, 1992·Journal of Cardiovascular Pharmacology·G L BartelsN M Knufman
Oct 15, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·R J Morrow, M E Rose
Feb 14, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·J FarquharsonR W Logan
Feb 1, 1991·Journal of Molecular and Cellular Cardiology·S D DaTorreP B Corr
Dec 1, 1988·The American Journal of Physiology·C M Liedtke
Jul 31, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·N SiliprandiF Di Lisa
Jan 1, 1988·Annual Review of Biochemistry·L L Bieber
Jan 1, 1988·Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete·B Künnert
May 29, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·A K BhuiyanK Bartlett
Oct 15, 1987·Biochemical Pharmacology·B MeleghL L Bieber
Jan 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·D S MillingtonD J Liberato
Dec 1, 1984·The Journal of Clinical Investigation·C R RoeT P Bohan
Jun 1, 1984·The Journal of Clinical Investigation·C R RoeC L Hoppel
Jan 1, 1995·Journal of Inherited Metabolic Disease·J S SchlenzigJ M Saudubray
Aug 1, 1995·European Journal of Pediatrics·J S SchlenzigJ P Harpey
Oct 1, 1994·European Journal of Pediatrics·A C SewellR J Wanders
Aug 19, 1994·Journal of Chromatography. B, Biomedical Applications·A KumpsY Mardens
Jan 1, 1994·European Journal of Pediatrics·H BöhlesA Sewell
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·M K ShigenagaB N Ames
Sep 1, 1994·The American Journal of Clinical Nutrition·H G OlbrichH Böhles
Jul 1, 1993·The American Journal of Medicine·G Sekas, H S Paul
Dec 2, 1964·Biochimica Et Biophysica Acta·D J PEARSON, P K TUBBS

❮ Previous
Next ❯

Citations

Apr 2, 1999·Early Human Development·C CampoyJ A Molina-Font
Sep 1, 2012·The Pediatric Infectious Disease Journal·Brian KirmseWilliam Borkowsky
Jan 8, 2009·BMC Systems Biology·Robert Modre-OsprianArmin Graber
Apr 14, 2012·The Journal of Nutrition, Health & Aging·R Bieżanowska-Kopeć, T Leszczyńska
Nov 10, 2015·AIDS Research and Human Retroviruses·Brian KirmseMarshall Summar
Mar 26, 2011·Journal of Clinical Laboratory Analysis·Tanima DeRita Christopher
Nov 12, 2002·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J H Osorio, M Pourfarzam
Apr 4, 2007·The British Journal of Nutrition·Eun-Mi AhnYoun-Soo Cha
Mar 19, 2004·The Journal of Perinatal & Neonatal Nursing·Sandra A Banta-Wright, Robert D Steiner
Mar 20, 2018·Scientific Reports·Margherita RuoppoloIlaria Campesi
Jan 5, 2002·Progress in Lipid Research·Mary C Hunt, Stefan E H Alexson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.